Multiplex Bead Mixes Made Easy with an Excel-Based Bead Calculator

Whether you’re developing a multiplex assay for 500 different markers in one reaction or developing lower-plex assays, knowing how to make a multiplex bead mix from different types of bead stocks is critical for proper assay performance. Unconjugated beads can be purchased as individual stocks at different concentrations of 12.5 or 2.5 million beads per [Read More…]

Training Tomorrow’s Custom Assay Development Experts: A Summer Internship Program Hosted by the LuminexPLORE Lab

UT Austin students share their experience working in our xMAP® Custom Assay Development lab this past summer Internships in our industry aren’t particularly common, and they’re even harder to find in places like Austin, which isn’t really considered a biotech hub. However, it’s important to offer these types of programs so that students interested in [Read More…]

Bead-Based Multiplex Assay Shines in Performance Analysis

xMAP® Technology offers significant advantages in recent comparison to electrochemiluminescence platform. It’s clear why multiplex immunoassays play a prominent role in many modern laboratories. In addition to saving time, labor, and resources, multiplexing provides simultaneous quantification of multiple targets within small sample volumes. Different multiplex platforms have individual strengths, and in a recent study, scientists [Read More…]

Luminex Licensed Technologies Partner Spotlight:  EpiCypher

EpiCypher delivers high-quality reagents for epigenetics and chromatin research As one of Luminex’s Licensed Technologies Partners, EpiCypher is one of many companies that uses xMAP® Technology to deliver important solutions for improving research and molecular diagnostics. Based out of the Research Triangle Park in North Carolina, EpiCypher is a biotechnology company that helps scientists push [Read More…]

Coming Soon: A New Multiplex Serology Test for SARS-CoV-2

Luminex Partner Tetracore designed a serology assay for SARS-CoV-2 using xMAP® Technology. A new multiplex serology test to determine whether someone has been exposed to the SARS-CoV-2 virus is coming soon, thanks to assay developer Tetracore. The company—one of Luminex’s research partners—developed this test based on our xMAP Technology. We spoke with Tetracore Senior Scientist [Read More…]